Dechra Pharmaceuticals PLC
LSE:DPH

Watchlist Manager
Dechra Pharmaceuticals PLC Logo
Dechra Pharmaceuticals PLC
LSE:DPH
Watchlist
Price: 3 866 GBX Market Closed
Market Cap: 440.4B GBX
Have any thoughts about
Dechra Pharmaceuticals PLC?
Write Note

Intrinsic Value

The intrinsic value of one DPH stock under the Base Case scenario is 58.36 GBX. Compared to the current market price of 3 866 GBX, Dechra Pharmaceuticals PLC is Overvalued by 98%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DPH Intrinsic Value
58.36 GBX
Overvaluation 98%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Dechra Pharmaceuticals PLC

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
DPH
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for DPH cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about DPH?
Bearish
Neutral
Bullish

Fundamental Analysis

3 866 GBX
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Dechra Pharmaceuticals PLC
UK
Pharmaceuticals
Market Cap
440.4B GBX
IPO
Sep 21, 2000
Employees
1 945
United Kingdom
Market Cap
440.4B GBX
Industry
Pharmaceuticals
IPO
Sep 21, 2000
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Dechra Pharmaceuticals PLC

Provide an overview of the primary business activities
of Dechra Pharmaceuticals PLC.

What unique competitive advantages
does Dechra Pharmaceuticals PLC hold over its rivals?

What risks and challenges
does Dechra Pharmaceuticals PLC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Dechra Pharmaceuticals PLC.

Provide P/S
for Dechra Pharmaceuticals PLC.

Provide P/E
for Dechra Pharmaceuticals PLC.

Provide P/OCF
for Dechra Pharmaceuticals PLC.

Provide P/FCFE
for Dechra Pharmaceuticals PLC.

Provide P/B
for Dechra Pharmaceuticals PLC.

Provide EV/S
for Dechra Pharmaceuticals PLC.

Provide EV/GP
for Dechra Pharmaceuticals PLC.

Provide EV/EBITDA
for Dechra Pharmaceuticals PLC.

Provide EV/EBIT
for Dechra Pharmaceuticals PLC.

Provide EV/OCF
for Dechra Pharmaceuticals PLC.

Provide EV/FCFF
for Dechra Pharmaceuticals PLC.

Provide EV/IC
for Dechra Pharmaceuticals PLC.

Show me price targets
for Dechra Pharmaceuticals PLC made by professional analysts.

What are the Revenue projections
for Dechra Pharmaceuticals PLC?

How accurate were the past Revenue estimates
for Dechra Pharmaceuticals PLC?

What are the Net Income projections
for Dechra Pharmaceuticals PLC?

How accurate were the past Net Income estimates
for Dechra Pharmaceuticals PLC?

What are the EPS projections
for Dechra Pharmaceuticals PLC?

How accurate were the past EPS estimates
for Dechra Pharmaceuticals PLC?

What are the EBIT projections
for Dechra Pharmaceuticals PLC?

How accurate were the past EBIT estimates
for Dechra Pharmaceuticals PLC?

Compare the revenue forecasts
for Dechra Pharmaceuticals PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Dechra Pharmaceuticals PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Dechra Pharmaceuticals PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Dechra Pharmaceuticals PLC compared to its peers.

Compare the P/E ratios
of Dechra Pharmaceuticals PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Dechra Pharmaceuticals PLC with its peers.

Analyze the financial leverage
of Dechra Pharmaceuticals PLC compared to its main competitors.

Show all profitability ratios
for Dechra Pharmaceuticals PLC.

Provide ROE
for Dechra Pharmaceuticals PLC.

Provide ROA
for Dechra Pharmaceuticals PLC.

Provide ROIC
for Dechra Pharmaceuticals PLC.

Provide ROCE
for Dechra Pharmaceuticals PLC.

Provide Gross Margin
for Dechra Pharmaceuticals PLC.

Provide Operating Margin
for Dechra Pharmaceuticals PLC.

Provide Net Margin
for Dechra Pharmaceuticals PLC.

Provide FCF Margin
for Dechra Pharmaceuticals PLC.

Show all solvency ratios
for Dechra Pharmaceuticals PLC.

Provide D/E Ratio
for Dechra Pharmaceuticals PLC.

Provide D/A Ratio
for Dechra Pharmaceuticals PLC.

Provide Interest Coverage Ratio
for Dechra Pharmaceuticals PLC.

Provide Altman Z-Score Ratio
for Dechra Pharmaceuticals PLC.

Provide Quick Ratio
for Dechra Pharmaceuticals PLC.

Provide Current Ratio
for Dechra Pharmaceuticals PLC.

Provide Cash Ratio
for Dechra Pharmaceuticals PLC.

What is the historical Revenue growth
over the last 5 years for Dechra Pharmaceuticals PLC?

What is the historical Net Income growth
over the last 5 years for Dechra Pharmaceuticals PLC?

What is the current Free Cash Flow
of Dechra Pharmaceuticals PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Dechra Pharmaceuticals PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dechra Pharmaceuticals PLC

Current Assets 467.9m
Cash & Short-Term Investments 74.4m
Receivables 176.2m
Other Current Assets 217.3m
Non-Current Assets 1.1B
Long-Term Investments 14.9m
PP&E 159.3m
Intangibles 922.4m
Other Non-Current Assets 4.9m
Current Liabilities 164m
Accounts Payable 144.5m
Other Current Liabilities 19.5m
Non-Current Liabilities 650.2m
Long-Term Debt 500.6m
Other Non-Current Liabilities 149.6m
Efficiency

Earnings Waterfall
Dechra Pharmaceuticals PLC

Revenue
761.5m GBP
Cost of Revenue
-331.9m GBP
Gross Profit
429.6m GBP
Operating Expenses
-404.7m GBP
Operating Income
24.9m GBP
Other Expenses
-52.8m GBP
Net Income
-27.9m GBP

Free Cash Flow Analysis
Dechra Pharmaceuticals PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

DPH Profitability Score
Profitability Due Diligence

Dechra Pharmaceuticals PLC's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive Free Cash Flow
50/100
Profitability
Score

Dechra Pharmaceuticals PLC's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

DPH Solvency Score
Solvency Due Diligence

Dechra Pharmaceuticals PLC's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Low D/E
Long-Term Solvency
52/100
Solvency
Score

Dechra Pharmaceuticals PLC's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DPH Price Targets Summary
Dechra Pharmaceuticals PLC

There are no price targets for DPH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for DPH?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for DPH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one DPH stock?

The intrinsic value of one DPH stock under the Base Case scenario is 58.36 GBX.

Is DPH stock undervalued or overvalued?

Compared to the current market price of 3 866 GBX, Dechra Pharmaceuticals PLC is Overvalued by 98%.

Back to Top